Ecurater Journals

Archives of Cancer Research & Medicine

Aim & Scope

The Scope of this Journal includes Cancer Research, Cancer Medicine, Cancer Surgery, Tumor, Oncology, Immune-Oncology, Carcinogenesis, Melanoma, Sarcoma, Metastasis, Chemotherapy, Leukemia, Cancer Therapeutics, Cancer Epidemiology, Cancer Prevention, Clinical Trials, Cancer Cytopathology, Stem Cell Therapy, DNA Repair in Cancer Therapy and related areas.

Editorial Board

Dr. Adrián P. Huñis
Medical Specialist in Clinical Oncology
Buenos Aires, Argentina
Dr. Michael J. Gonzalez
Professor
University of Puerto Rico Medical Sciences
Puerto Rico, U.S.A
Dr. Alain L. Fymat
President, CEO and Institute Professor
International Institute of Medicine and Science
Rancho Mirage, California, U.S.A
Dr. Jonas Cicenas
Senior Scientist
Institute of Biochemistry, Vilnius University Life Sciences Center
Vilnius, Lithuania, Europe
Dr. Sanjay Singh Chandel
Associate Professor
Department of Radiation Oncology, G.R Medical College
Gwalior, M.P., India
Dr. Bhuvnesh K. Sharma
Senior Director, R&D (Translational Oncology)
ScyTeK Laboratories Inc.
Logan, UT, USA
Dr. Daniela Capdepon
Oncologist Consultant & Senior Medical Director
Campana Cancer Centre
Argentina
Dr. Daniel Gandia
Medical Director, Hematology and Oncology
University of Buenos Aires
Buenos Aires, Argentina
Dr. Bhanu Patibandla
Director, Lung Nodule & Thoracic Oncology Program
PeaceHealth Southwest Medical Center
Vancouver, Washington, United States

Article in Press

Special Issue

Cancer Treatment – From Immunotherapy To Gene Therapy And Beyond

Article Type : Editorial
Author : Alain L. Fymat *

Abstract

Cancer is the oldest disease having affected humankind. Attempts to treat it have taken the shape of a “war” and have best been described in military terms. So far, despite winning some battles, we have waged that war without focus and unsuccessfully for the past 4,000 years with an accelerated campaign only during the last four decades. We rarely saw the enemy as it hid behind other diseases (cholera, dropsy, leprosy, plague, pneumonia, smallpox, and tuberculosis) and mostly affected the older populations. However, with increasing lifespan and a partial clearing of these other diseases, cancer came back in full force and roaring. From the earliest accounts dating to the Greek historian Herodotus (440 BC) within the context of breast cancer, the latest pronouncements of the World Health Organization (WHO) are that “ … cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths in 2018”. For 2020, the numbers of estimated cases/deaths for the various types of organ cancers were: breast (2.26 million/685,000), colon and rectum (1.93 million/935,000), liver (830,000 deaths), lung (2.21 million/1.8 million), prostate (1.41 million), skin (non-melanoma) (1.20 million), and stomach (1.09 million/769,000). Further, for 2021, model-based projections by the American Cancer Society (ACS) predicted 1,898,160 new cases and 608,570 additional deaths in the U.S.

Abstract Download Article View Full Article

Current Issue

Pattern of Neuroblastoma Among Children in Basra Pediatric Oncology Center

Article Type : Research
Author : Marwa Sabah Abdul Rahman, Janan G. Hasan*, Athar Abdul Samad and Hussam M.Salih
Abstract Download Article View Full Article

Community-Based Psychosocial Support Centers for Cancer Patients and Their Relatives: Use, Evaluation and Effect

Article Type : Research
Author : Adriaan Visser
Abstract Download Article View Full Article

Archives

Upcoming Special Issues

Call for papers

This Issue is now open for submissions until 15 June 2021.

Description

Cancer is among the main causes of mortality worldwide, and in the past decade, several research studies have focused in uncovering new therapies to reduce the side effects caused by conventional therapies. Oncological research is putting substantial efforts towards finding novel and efficient therapies which can attenuate critical side effects caused by conventional treatments. Different technologies are currently either under evaluation in clinical trials or have been already introduced into clinical practice. We are currently open for publication of such studies in form of research, review, case study, case series, opinion, commentary, short communication and opinion articles.

Potential topics include but are not limited to the following:

  • Gene Therapy
  • Chemotherapy
  • Cancer Immunotherapy
  • Interventions In Cancer
  • Chimeric Antigen Receptor T-cell Therapy
  • Radiation Therapy
  • Targeted Therapy
  • Hormone Therapy
  • Stem cell Therapy
  • Precision Therapy
  • Side Effects Of Cancer Treatment
  • Complementary And Alternative Medicine For Cancer Treatment
  • Biofield Therapy
  • Biomarkers
  • Nanomedicine
  • Cancer Surgery
  • Cancer Clinical Trials